echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nat Commun: Xiamen University Deng early summer team: NOTCH1 activation promotes the formation of triple negative breast cancer

    Nat Commun: Xiamen University Deng early summer team: NOTCH1 activation promotes the formation of triple negative breast cancer

    • Last Update: 2020-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Carriers of the BRCA1 mutation have a higher risk of developing triple-negativebreast cancer(TNBC), a refractive disease that does not respond to current clinical targeted therapiesusing the Sleeping Beauty transposonsystem in Brca1 missing mice, the Deng early summer team at Xiamen University identified 169 predicted cancer drivers, including NOTCH1 as the primary candidate to accelerate TNBC by promoting epithelial interstitial transformation (EMT) and regulating cell cyclesactivation of NOTCH1 can suppress fissional fragmentation caused by BRCA1 deletion by activating the ATR-CHK1 signal path and restoring the S/G2 and G2/M cell cycle checkpointsconsistently, analysis of breast cancer tissue in humans showed that NOTCH1 was expressed highly in TNBCs, and that the activation form of NOTCH1 was positively correlated with the increase of phosphorylation of ATR, the researchers demonstrated that inhibition of NOTCH1-ATR-CHK1 works with cisplatin and can be used to kill TNBC in a coordinated way with target cell cycle checkpoints, DNA damage, and EMT, providing an effective clinical option for this deadly disease
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.